Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 100-121

  Hausdorff, William P ^a   Bryant, John ^b   Paradiso, Peter R ^a   Siber, George R ^a  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DATA BASE; DRUG FORMULATION; GEOGRAPHIC DISTRIBUTION; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0033959859     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313608     Document Type: Article

References (106)

1. Advisory Committee on Immunization Practices. Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
2. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337:970-6.
3. Connolly M, Noah N. Surveillance of bacterial meningitis in Europe, 1996. London: King's European Meningitis Surveillance Unit, King's College School of Medicine and Dentistry, 1997.
4. Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3d ed. Philadelphia: WB Saunders, 1998:553-607.
5. Global Programme for Vaccines and Immunization. Report of the meeting of the Scientific Group of Experts (SAGE) of the Children's Vaccine Initiative and the Global Programme for Vaccines and Immunization. Geneva: World Health Organization, 1996.
6. Butler J, Hofmann J, Martin S, et al. The continued emergence of drug- resistant streptococcal pneumonia in the United States: an update from the CDC's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174:986-93.
7. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3:171-96.
8. Robbins JB, Austrian R, Lee CJ, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine, with emphasis on the cross-reactive types within groups. J Infect Dis 1983; 148:1136-59.
9. Scott JAG, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7000 episodes of invasive disease. Clin Infect Dis 1996; 22:973-81.
10. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997; 278:1333-9.
11. Klein JO. Pneumococcal otitis media vaccine trials. Pediatr Infect Dis J 1989; 8:S82-3.
12. Makela PH, Leinonen M, Pukander J, Karma P. A study of the pneumococcal vaccine in prevention of clinically acute attacks of recurrent otitis media. Rev Infect Dis 1981;3:S124-30.
13. Eby R. Pneumococcal conjugate vaccines. In: Powell MF, Newman MJ, eds. Pharmaceutical biotechnology. Vol. 6. Vaccine design: the subunit and adjuvant approach. New York: Plenum Press, 1995:695-718.
14. Sniadack DH, Schwartz B, Lipman H, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children implications for vaccine strategies. Pediatr Infect Dis J 1995; 14:503-10.
15. Shen SJ, the Cooperation Group on Pneumococcal Serotyping. Serotypes and epidemiological study of pneumococcal infection in 18 provinces (cities) in China. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 1989; 10: 133-7.
16. Kellner JD, McGeer A, Cetron MS, et al. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J 1998; 17:279-86.
17. Scott JAG, Hall AJ, Hannington A, et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates form the coast of Kenya. Clin Infect Dis 1998;27:1442-50.
18. Di Fabio JL, Homma A, deQuadros C. Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae. Microb Drug Resist 1997; 3:131-3.
19. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis 1994; 169:212-4.
20. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986 1990. J Infect Dis 1994; 170:461-4.
21. Orange M, Gray BM. Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J 1993; 12:244-5.
22. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978 1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171:885-9.
23. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. JAMA 1993; 270: 1826-31.
24. Loughlin AM, Marchant CD, Lett SM. The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991. Am J Public Health 1995; 85:392-4.
25. Hibbs JR, John MD Jr, Judson FN, McGill WL, Rietmeijer CAM, Janoff EN. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin Infect Dis 1997; 25:195-9.
26. Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in Southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174:752-9.
27. Black S, Schinefield H, Elvin L, Schwalbe J, Fireman B. Pneumococcal epidemiology in childhood in a large HMO population [abstract G71]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1994.
28. Lovgren M, Spika JS, Talbot JA. Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1955. Can Med Assoc J 1998; 158:327-31.
29. Plouffe JF, Moore SK, Davis R, Facklam RR. Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio. J Clin Microbiol 1994; 32:1606-7.
30. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. JAMA 1996; 275:194-8.
31. Kaplan SL, Mason EO, Barson WJ et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998; 102: 538-44.
32. Hsueh P-R, Uw J-J, Hsiue T-R. Invasive Streptococcus pneumoniae infection associated with rapidly fatal outcome in Taiwan. J Formos Med Assoc 1996; 95:364-71.
33. Saha SK, Rikitomi N, Biswas D, et al. Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995. J Clin Microbiol 1997; 35:785-7.
34. Dagan R, Englehard D, Piccard E. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA 1992; 268:3328-32.
35. Rahav G, Toledano Y, Engelhard D, et al. Invasive pneumococcal infections: a comparison between adults and children. Medicine 1997; 76:295-303.
36. Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Clin Infect Dis 1997;24:1164-8.
37. Lakshmy A, Malhotra VL. Serotype distribution of clinical isolates of Streptococcus pneumoniae from a Delhi hospital. Adv Exp Med Biol 1997; 418:273-4.
38. Invasive Bacterial Infection Surveillance (IBIS) Group I. Prospective multicenter hospital surveillance of Streptococcus pneumoniae disease in India. Lancet 1999; 353:1216-21.
39. Capeding MRZ, Sombrero LT, Lucero MG, Saniel MC. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children. J Infect Dis 1994; 169:479-80.
40. Mastro TD, Ghaffor A, Nomani NK, et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 1991; 337:156-9.
41. Guirguis NI, Helmy MF, Mohamed MR, Ali RH. A suggested vaccine formulation for the control of pneumococcal meningitis in Egypt. J Egypt Public Health Assoc 1990; 65:291-303.
42. Muhe L, Klugman K. Pneumococcal and haemophilus meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns. Trop Med Int Health 1999;4:421-7.
43. Bogaerts J, Lepage P, Taelman H, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990. J Infect 1993;27:157-68.
44. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992; 146:920-3.
45. Crewe-Brown HH, Karstaedt AS, Saunders GI, et al. Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis 1997;25:1165-72.
46. O'Dempsey TJD, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of West Africa. Pediatr Infect Dis J 1996; 15:431-7.
47. Usen S, Adegbola R, Mulholland K, et al. Epidemiology of invasive pneumococcal disease in the western region. The Gambia. Pediatr Infect Dis J 1998; 17:23-8.
48. Paul J, Bates J, Kimari J, Gilks C. Serotypes and antibiotic susceptibilities of Streptococcus pneumoniae in Nairobi, Kenya. J Infect 1996; 32:139-42.
49. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 268:3323-7.
50. Sankilampi U, Herva E, Huikala R, Liimatainen O, Renkonen O-V, Leinonen M. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect 1997; 118:7-15.
51. Urwin G, Yuan MF, Hall LMC, Brown K, Efstratiou A, Feldman RA. Pneumococcal meningitis in the northeast Thames region. United Kingdom: epidemiology and molecular analysis of isolates. Epidemiol Infect 1996; 117:95-102.
52. Colman G, Cooke EM, Cookson BD, Cooper PG, Efstratiou A, George RC. Pneumococci causing invasive disease in Britain, 1982-1990. J Med Microbiol 1998; 47:17-27.
53. George RC, Efstratiou A, Broughton K, Waight PA, Miller E, Speller DCE. Invasive pneumococcal infection in children aged less than 6 years in England and Wales during 1995 and 1996 [abstract P555]. J Clin Microbiol Infect 1997;3(Suppl 2)P555:130.
54. Kornelisse RF, Westerbeek CML, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995; 21: 1390-7.
55. Kornelisse RF, Sluijter M, Spanjaard L, Hermans PWM, de Groot R. Molecular epidemiological characteristics of pneumococcal meningitis in children. Eur J Clin Microbiol Infect Dis 1996; 15:635-8.
56. Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM). Bacterial meningitis in the Netherlands: annual report, 1996. Amsterdam: University of Amsterdam, 1997.
57. Linares J, Pallares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15:99-105.
58. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19:884-90.
59. Fenoll A, Jado I, Viciso D, Perez A, Casai J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36:3447-54.
60. Fenoll A, Bourgon CM, Mnunoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991; 13:56-60.
61. Magnus T, Andersen BM. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway. Eur J Clin Microbiol Infect Dis 1995; 14:229-34.
62. Verhaegen J, Glupezynski Y, Verbist I, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis 1995; 20:1339-45.
63. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 1996; 117:411-6.
64. Hedlund J, Svenson SB, Kalin M, et al. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis 1995; 21:948-53.
65. Kragsbjerg P, Kallman J, Olcen P. Pneumococcal meningitis in adults. Scand J Infect Dis 1994;26:659-66.
66. Geslin P, Fremaux A, Sissia G, Spicq C, Aberrane S. Rapport d'activite annee 1996. Paris: Centre National de Reference des Pneumocoques, 1996.
67. Geslin P, Fremaux A, Sissia G, Spicq C. Streptococcus pneumoniae: serotypes, souches invasives et resistantes aux antibiotiques. Situation actuelle en France. Presse Med 1998;27:521-7.
68. Reinert RR, Kaufhold A, Schlaeger JJ, Mechery V, Lutticken R. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996. Pediatr Infect Dis J 1997; 16:244-5.
69. Reinert RR, Queck A, Kaufhold A, Kresken M, Lutticken R. Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994. Clin Infect Dis 1995;21:1398-401.
70. Wust J, Huf E, Kayser FH. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland. J Clin Microbiol 1995;33:3159-63.
71. Rossi A, Ruvinsky R, Regueira M, Corso A, Pace J, Gentile A. Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Microb Drug Resist 1997;3:135-40.
72. Brandileone MCDC, Vieira VSD, Casagrande ST, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Microb Drug Resist 1997;3:141-6.
73. Brandileone MCDC, Vieira VSD, Zanella RC, et al. Austrian R. Distribution of serotypes of Streptococcus puemoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil. J Clin Microbiol 1995;33:2789-91.
74. Castaneda E, Leal AL, Castillo O, et al. Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Columbian children. Microb Drug Resist 1997;3:147-52.
75. Echaniz-Aviles G, Velazquez-Meza MAE, Carnalla-Barajas MN, et al. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City. Microb Drug Resist 1997;3:153-7.
76. Echaniz-Aviles G, Carnalla-Barajas N, Velazquez-Meza ME, Soto-Norgueron A, Espinoza de los Monteros L, Solorzano-Santos F. Capsular types of Streptococcus pneumoniae causing disease in children from Mexico City. Pediatr Infect Dis J 1995; 14:907-9.
77. Hortal M, Algorta G, Bianchi I, et al. Capsular type distribution and susceptibility to antibiotics of Streptococcus pneumoniae clinical strains isolated from Uruguayan children with systemic infections. Microb Drug Resist 1997; 3:159-63.
78. Mogdasy MC, Camou T, Fajardo C, Hortal M. Colonizing and invasive strains of Streptococcus pneumoniae in Uruguayan children: type distribution and patterns of antibiotic resistance. Pediatr Infect Dis J 1992; 11:648-52.
79. Levine MM, Lagos R, Levine OS, et al. Epidemiology of invasive pneumococcal infections in infants and young children in metropolitan Santiago, Chile, a newly industrializing country. Pediatr Infect Dis J 1998; 17:287-93.
80. Gratten M, Montgomery J. The bacteriology of acute pneumonia and meningitis in children in Papua New Guinea: assumptions, facts and technical strategies. Papua New Guinea Med J 1991;34:185-98.
81. Gratten M, Torzillo P, Morey F, et al. Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in central Australia. J Clin Microbiol 1996; 34:338-41.
82. Trotman J, Hughes B, Mollison L. Invasive pneumococcal disease in central Australia. Clin Infect Dis 1995;20:1553-6.
83. Voss L, Lennon D, Okesene-Gafa K, Ameratunga S, Martin D. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatr Infect Dis J 1994; 13:873-7.
84. Martin DR, Brett MS. Pneumococci causing invasive disease in New Zealand, 1987-94: serogroup and serotype coverage and antibiotic resistance. N Z Med J 1996; 109:288-90.
85. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000; 30:122-40.
86. George R, Johnson AP, Speller DC, Efstratiou A, Broughton K, Patel BC. Serogroups/types and antibiotic resistance of referred isolates of Streptococcus pneumoniae: 1993 to 1995. Commun Dis Rep CDR Rev 1997;7:R159-64.
87. Siedler A, van Kries R, Lutticken R, Reinert RR. Nation-wide study on systemic pneumoccoccal infections among children in Germany, 1997 (abstract 11). In: Program and abstracts of the Pneumococcal Vaccines for the World 1998 Conference, 12-14 Oct, 1998, Washington, DC. Washington, DC: 1998.
88. Austrian R. The enduring pneumococcus: unfinished business and opportunities for the future. Microb Drug Resist 1997;3:111-5.
89. Obaro S, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination [letter]. Lancet 1996; 348:271-2.
90. Mbelle N, Wasas A, Huebner RE, Wasa AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonvalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180:1171-6.
91. Ekdahl K, Martensson A, Kamme C. Bacteraemic pneumococcal infections in southern Sweden, 1981-1996: trends in incidence, mortality, age-distribution, serogroups and penicillin-resistance. Scand J Infect Dis 1998; 30:257-62.
92. Cizman M, Paragi M, Gubina M, the Slovenian Meningitis Study Group. Epidemiology of invasive S. pneumoniae (SP) in children and adults in Slovenia, 1996-1997 [abstract 40]. In: Program and abstracts of the Pneumococcal Vaccines for the World 1998 Conference, 12-14 Oct, 1998, Washington, DC. Washington, DC: 1998.
93. Nielsen S, Henrichsen J. Capsular types and susceptibility to penicillin of pneumococci isolated from cerebrospinal fluid or blood in Denmark, 1983-1988. Scand J Infect Dis 1993;25:165-70.
94. Fraser D, Yagupsky P, Dagan R. A decade of pediatric invasive pneumococcal disease (IPD) in two populations residing in southern Israel: implications for vaccine choice (abstract 26). In: Program and abstracts of the Pneumococcal Vaccines for the World 1998 Conference, 12-14 Oct, 1998, Washington, DC. Washington, DC: 1998.
95. Rohani MY, Raudzah A, Ng AJ, et al. Epidemiology of Streptococcus pneumoniae infection in Malaysia. Epidemiol Infect 1999; 122:77-82.
96. Coelho HE. Study to determine prevalence of antibiotic-resistant Streptococcus pneumoniae in Maputo, Mozambique. Johannesburg, South Africa: University of the Witwatersrand, 1998.
97. Gilmour R, McIntyre P, Heath TC, et al. Invasive pneumococcal disease in urban New South Wales, Australia (abstract 52). In: Program and abstracts of the Pneumococcal Vaccines for the World 1998 Conference12-14 Oct 1998, Washington, DC. Washington, DC: 1998.
98. Gratten M, Carlisle J, Hanna J, et al. Seroepidemiology of invasive pneumococcal disease in Queensland, 1990 to 1997. Commun Dis Intell 1998;22:265-8.
99. Diez Domingo J, Morant A, Pereiro I, Gimeno C, Brines J, Gonzalez A. Childhood invasive pneumococcal disease in Valencia, Spain: population-based surveillance system [abstract P-140]. In: Program and abstracts of the 17th Annual Meeting of the European Society for Paediatric Infectious Diseases, Crete, Greece. Munich: European Society for Pediatric Infectious Diseases, 1999.
100. Barnett ED, Pelton SI, Cabral HJ, et al. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children. Clin Infect Dis 1999;29:191-2.
101. Musher DM, Groover JE, Watson DA, Rodriguez-Barradas MC, Baughn RE. IgG responses to protein-conjugate pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugate polysaccharides. Clin Infect Dis 1998;27:1487-90.
102. Kertesz DA, DiFabio JL, Brandileone MCC, et al. Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization surveillance study. Clin Infect Dis 1998;26:1355-61.
103. Lee H-J. Pneumococcal infections in the Republic of Korea: epidemiology in adults, serotypes, and antibiotic resistance (abstract 91). In: Program and abstracts of the 1st International Symposium on Adult Immunization in Asia: Prevention of Influenza and Pneumococcal Infections, Hanoi. Lyon: Foundation Marcel Mėrieux, 1998.
104. Inostroza J, Trucco O, Prado V, et al. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolated in two Chilean cities. Clin Diagn Lab Immunol 1998;5:176-80.
105. Koh TH, Lin RVTP. Increasing antimicrobial resistance in clinical isolates of Streptococcus pneumoniae. Ann Acad Med Singapore 1997;26:604-8.
106. Black S, Shinefield H, Ray T, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: results of the Northern California Kaiser Permanente Efficacy Trial [abstract LB-9]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998.